Kurma Growth Opportunities Fund
Pariskurmapartners.com
Overview
Kurma Growth Opportunities Fund is a 2022 vintage growth and expansion fund that invests in European life sciences, health tech, pharmaceuticals, and biotechnology companies. The fund focuses on late-stage, crossover, and public financing rounds for companies transitioning from the R&D to the commercial stage.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NUCLIDIUM AG | May 2026 | Series B Extension | Lead |
| NUCLIDIUM AG | Jul 2025 | Series B | Lead |
| Vico | Jun 2024 | Series B Extension | Co-investor |
Key People
Thierry Laugel
Managing Partner
Dominique Poiroux
Venture Partner
Amanda Gett-Chaperot
Partner
Benjamin Belot
Partner - Investing In Healthtech, AI TechBio
Daniel Parera
Partner
Hadrien Bouchez
Partner
Sylvain Cascarino
CFO - Partner
Séverine PENOT
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.